Innoviva (INVA) Leases (2011 - 2026)
Innoviva posted quarterly Leases of $10.7 million for Q1 2026, up 404.83% year-on-year from $2.1 million in Q1 2025, and down 2.53% on a QoQ basis from $10.9 million in Q4 2025.
Innoviva (INVA) has 8 years of Leases data on file, last reported at $10.7 million in Q1 2026.
- For the quarter ending Q1 2026, Leases rose 404.83% year-over-year to $10.7 million; the trailing twelve-month figure through Mar 2026 stood at $10.7 million (up 404.83% YoY), and the FY2025 full-year result was $10.9 million, up 345.54% from the prior year.
- Leases for Q1 2026 stood at $10.7 million, down from $10.9 million in the prior quarter.
- Across five years, Leases topped out at $10.9 million in Q4 2025 and bottomed at $1.4 million in Q3 2025.
- The 5-year median for Leases is $2.8 million (2023), against an average of $3.7 million.
- The widest annual swing landed in 2022, when Leases surged 3265.98%; it then sank 49.73% in 2025.
- A 5-year view of Leases shows it stood at $3.3 million in 2022, then retreated by 22.33% to $2.5 million in 2023, then decreased by 3.27% to $2.5 million in 2024, then surged by 345.54% to $10.9 million in 2025, then decreased by 2.53% to $10.7 million in 2026.
- The last three Leases figures came in at $10.7 million (Q1 2026), $10.9 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 10.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.65 Mn |
| Dec 31, 2025 | 10.93 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.76 Mn |
| Mar 31, 2025 | 2.11 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 2.27 Mn |
| Dec 31, 2023 | 2.54 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 2.72 Mn |
| Mar 31, 2023 | 2.97 Mn |
| Dec 31, 2022 | 3.27 Mn |
| Sep 30, 2022 | 3.68 Mn |
| Jun 30, 2022 | 3.55 Mn |
| Mar 31, 2022 | 3.79 Mn |
| Dec 31, 2021 | 97,000.00 |
| Jun 30, 2019 | 1.35 Mn |
| Mar 31, 2019 | 1.42 Mn |
| Dec 31, 2011 | 200,000.00 |